Tissue Engineering Applications Combining Biomaterial Scaffolds with Stem Cells Will Facilitate Delivery of Targeted Therapies
24 April 2019 | Amsterdam, NL – StemJournal, a new open access, peer-reviewed journal published by IOS Press, announces publication of its inaugural article, “Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery” by Stephanie M. Willerth, PhD, and Shelly E. Sakiyama-Elbert, PhD.
Noted stem cell researchers present a state-of-the-art review in the inaugural article published in StemJournal
Amsterdam, NL – StemJournal, a new open access, peer-reviewed journal published by IOS Press, announces publication of its inaugural article, “Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery” by Stephanie M. Willerth, PhD, and Shelly E. Sakiyama-Elbert, PhD.
This timely overview of the available biomaterials for directing stem cell differentiation as a means of producing replacements for diseased or damaged tissues is a comprehensive update of the classic review published in StemBook in 2008.
"In the 10 years since the publication of our review, the field of stem biology has advanced rapidly as regenerative medicine strategies move into clinical trials for a variety of health disorders," explain Dr. Willerth, of the Department of Mechanical Engineering and Division of Medical Sciences, University of Victoria; and the International Collaboration on Repair Discoveries, University of British Columbia, and Dr. Sakiyama-Elbert, of the Department of Biomedical Engineering, University of Texas-Austin. "The biomaterials have improved along with drug delivery systems for promoting the desired stem cell behavior, as have methods for confirming tissue function. The field of tissue engineering has also advanced significantly in harnessing the potential of pluripotent stem cells. Another exciting area is the development of novel bio-inks for 3D printing stem cell-derived tissues."
Stem cells possess two novel properties: the ability to produce additional stem cells and the capacity to become multiple cell types. The major types of stem cells include adult, embryonic, fetal, induced pluripotent, and mesenchymal stem cells. Both natural and synthetic biomaterials can serve as the starting point for generating bioactive scaffolds for controlling stem cell differentiation into the desired tissue type. Types of scaffolds include hydrogels, micro- and nanofibers, and micro- and nanospheres.
This review encapsulates current foundational knowledge on general concepts that apply when combining biomaterial scaffolds with stem cells for tissue engineering applications, including the widespread adoption of induced pluripotent stem cells. Presenting promising strategies for engineering tissues for both in vitro and in vivo applications, it covers:
Types of Scaffold Formulations – Both natural and synthetic biomaterials can serve as the starting point for generating bioactive scaffolds for controlling stem cell differentiation into the desired tissue type.
Natural Biomaterials – The proteins and polysaccharides found in the extracellular matrix provide an obvious starting point when developing scaffolds derived from natural biomaterials.
Synthetic Biomaterials – Synthetic biomaterials provide an alternative to natural materials for engineering tissues from stem cells and offer many advantages.
Ceramic-Based Biomaterials – Ceramics, inorganic materials formed through treatment with heat, possess crystalline structures, meaning they are often porous and brittle.
While many of these materials have not been fully developed for specific tissue engineering applications, further work will continue to optimize these formulations for translation to the clinic for targeted applications. For example, optimized scaffolds could enhance the survival and differentiation of neural stem cells being transplanted into the diseased or damaged nervous system, which could lead to improved function. The type of material and the cues that are incorporated in the scaffold play a large role in directing the fate of the stem cells seeded inside, as detailed in this review.
According to the authors, the ability to further functionalize the materials discussed in this review in terms of their mechanical and chemical properties provides an excellent opportunity for future work, because such bioactive and instructive scaffolds can improve cell survival and differentiation into the desired phenotypes. The method of fabrication serves as an important parameter, which allows different types of patterns and architecture to be formed, which include hydrogels, microcarriers, fibers, and 3D bioprinted constructs. The latter offers the possibility of printing constructs to fill an injury site, as well as the ability to produce tissues with complex structures containing multiple cell types.
The future of this line of stem cell research is promising. "The ability to make universal induced pluripotent stem cell lines for engineering replacement tissues would be a game changer as it would make it easier to rapidly deliver effective, personalized therapies. Cellular reprogramming also has tremendous promise in terms of cell therapy," comment Dr. Willerth and Dr. Sakiyama-Elbert.
Dr. Willerth would like to acknowledge funding from the Canada Research Chairs program, the Natural Science and Engineering Research Council, the Stem Cell Network, and the British Columbia Innovation Council’s Ignite Program. Dr. Sakiyama Elbert would like to acknowledge funding from the NIH (NINDS R01 NS090617).
For additional information contact Carmel McNamara, IOS Press (+31 20 688 3355 or firstname.lastname@example.org). Journalists who wish to interview the authors should contact Shelly Sakiyama-Elbert, University of Texas-Austin (+1 512 471 3604 or email@example.com).
About StemJournal StemJournal is an international, multidisciplinary, open access forum for communicating outstanding stem cell research, including basic biology, clinical applications, disease modeling, computational and systems biology, and data science. One of its primary aims is to lower the barrier to publishing truly integrative biomedical research on stem cells. Its content includes research reports, review articles, and protocols. stemjnl.org
Along with the relaunch of StemBook, an online open access forum and discussion platform for the stem cell research community, IOS Press has opened new, dynamic channels for scientific contributions from the many fields of research on stem cells. It also paves the way for developing a much larger hub.
About IOS Press
IOS Press is headquartered in Amsterdam with satellite offices in the USA, Germany, India and China and serves the information needs of scientific and medical communities worldwide. IOS Press now publishes more than 80 international peer-reviewed journals and about 75 book titles each year on subjects ranging from computer science, artificial intelligence, and engineering to medicine, neuroscience, and cancer research. iospress.com